Across TCGA pan-cancer cohorts, MIR1202 RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated MIR1202 data layer compared with 1 for mutation status.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher MIR1202 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated MIR1202 expression acts as an unfavorable survival marker, although some lineages such as HNSC and ESCA show a favorable association.

HNSC, LGG, and ESCA are the cancer types where MIR1202 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	DFS	Tertile	III,IV	1.000	0.282	.015	39	view →
LGG	OS	Tertile	All	0.128	0.811	<.001	36	view →
ESCA	OS	Tertile	III,IV	1.000	0.365	.018	24	view →
THYM	DFS	Tertile	All	0.454	0.734	.042	6	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: MIR1202 tumor-vs-normal RNA expression · all MIR1202 data types